| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1993PNAS...90.9988O |
| P356 | DOI | 10.1073/PNAS.90.21.9988 |
| P932 | PMC publication ID | 47698 |
| P698 | PubMed publication ID | 8234346 |
| P5875 | ResearchGate publication ID | 14965636 |
| P2093 | author name string | W R Sherman | |
| I Herskowitz | |||
| J V Santiago | |||
| D M Kipnis | |||
| J B McGill | |||
| R E Ostlund | |||
| P2860 | cites work | Identification of a novel insulin-sensitive glycophospholipid from H35 hepatoma cells | Q42217432 |
| Myoinositol metabolism in diabetes mellitus. Effect of insulin treatment | Q44636422 | ||
| Partial structure of an insulin-sensitive glycophospholipid | Q68179413 | ||
| Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus | Q30456702 | ||
| Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol. | Q30460806 | ||
| Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators | Q30462224 | ||
| Second messengers of insulin action | Q37850168 | ||
| Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase | Q41809210 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9988-9992 | |
| P577 | publication date | 1993-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | D-chiro-inositol metabolism in diabetes mellitus | |
| P478 | volume | 90 |
| Q97521506 | A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome |
| Q28610092 | A stereospecific myo-inositol/D-chiro-inositol transporter in HepG2 liver cells. Identification with D-chiro-[3-3H]inositol |
| Q43753336 | An enzymatic cycling method for the measurement of myo-inositol in biological samples |
| Q28266269 | Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism |
| Q30434215 | D-Chiro-Inositol Glycans in Insulin Signaling and Insulin Resistance |
| Q28276074 | D-chiro-inositol found in Cucurbita ficifolia (Cucurbitaceae) fruit extracts plays the hypoglycaemic role in streptozocin-diabetic rats |
| Q42164648 | D-pinitol and myo-inositol stimulate translocation of glucose transporter 4 in skeletal muscle of C57BL/6 mice |
| Q44297709 | Determination of urinary myo-inositol concentration by an improved enzymatic cycling method using myo-inositol dehydrogenase from Flavobacterium sp. |
| Q38324369 | Differential gene expression in pancreatic tissues of streptozocin-induced diabetic rats and genetically-diabetic mice in response to hypoglycemic dipeptide cyclo (His-Pro) treatment. |
| Q54158115 | Effects of D-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys. |
| Q36034504 | Effects of acute pinitol supplementation on plasma pinitol concentration, whole body glucose tolerance, and activation of the skeletal muscle insulin receptor in older humans |
| Q36855851 | Experimental model proposed to deduce pharmacological evidence of the beta-cell neogenesis activity of Argyrolobium roseum vis-a-vis an evaluation of its hypoglycemic activity |
| Q37310914 | Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism |
| Q90418580 | Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes |
| Q37066270 | Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells |
| Q92481688 | Inositol and antioxidant supplementation: Safety and efficacy in pregnancy |
| Q38946449 | Inositol and human reproduction. From cellular metabolism to clinical use. |
| Q34248342 | Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. |
| Q36951616 | Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome |
| Q33989046 | LC-MS/MS method for the quantification of myo- and chiro-inositol as the urinary biomarkers of insulin resistance in human urine |
| Q40101741 | Metabolomic Determinants of Metabolic Risk in Mexican Adolescents |
| Q34097426 | Metabolomics Reveals Relationship between Plasma Inositols and Birth Weight: Possible Markers for Fetal Programming of Type 2 Diabetes |
| Q63441127 | Molecular structure of fagopyritol A1 (O-α-d-galactopyranosyl-(1→3)-d-chiro-inositol) by NMR |
| Q38161981 | Myoinositol: a new marker of intrauterine growth restriction? |
| Q47162682 | Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders |
| Q30571544 | Physiopathology of intrauterine growth retardation: from classic data to metabolomics |
| Q38205765 | Phytotherapy in diabetes: Review on potential mechanistic perspectives |
| Q36915041 | Pinitol supplementation does not affect insulin-mediated glucose metabolism and muscle insulin receptor content and phosphorylation in older humans |
| Q48284776 | Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology |
| Q43563560 | Purification and molecular structure of two digalactosyl D-chiro-inositols and two trigalactosyl D-chiro-inositols from buckwheat seeds. |
| Q35641269 | Quantification of myo-inositol, 1,5-anhydro- D-sorbitol, and D-chiro-inositol using high-performance liquid chromatography with electrochemical detection in very small volume clinical samples |
| Q40002269 | Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry. |
| Q36311686 | Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation. |
| Q89677290 | Simple and non-invasive screening method for diabetes based on myoinositol levels in urine samples collected at home |
| Q37502964 | The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry). |
| Q37070949 | The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol |
| Q35117211 | Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome |
| Q46421990 | Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus |
| Q46935436 | Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus |
| Q47432528 | Urinary metabolomics (GC-MS) reveals that low and high birth weight infants share elevated inositol concentrations at birth |
| Q51297245 | Urinary myo-inositol levels in Japanese schoolchildren with normal glucose tolerance. |
| Q37140717 | d- chiro-Inositol is absorbed but not synthesised in rodents |
| Q24533529 | myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol |
Search more.